Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi-Goutieres Syndrome, a Type I Interferonopathy

2019-01-22

ARTHRITIS & RHEUMATOLOGY , Volume 71 - Issue 5 p. 829- 831

Additional Metadata
Persistent URL	doi.org/10.1002/art.40805, hdl.handle.net/1765/116867
Journal	ARTHRITIS & RHEUMATOLOGY
Organisation	Department of Immunology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Meesilpavikkai, K., Dik, W., Schrijver, B., van Helden-Meeuwsen, C., Versnel, M., van Hagen, M., … Dalm, V. (2019). Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi-Goutieres Syndrome, a Type I Interferonopathy. ARTHRITIS & RHEUMATOLOGY, 71(5), 829–831. doi:10.1002/art.40805

Publication